Biosimilar Medication Formulary Updates
Sep. 2025Pharmacy Updates
Updates to formulary biosimilar medications for denosumab, eculizumab, and ustekinumab products
In ongoing efforts to improve the value and affordability of health care benefits for our members, UPMC Health Plan has implemented biosimilar medication formulary updates for denosumab, eculizumab, and ustekinumab products. Effective dates for these changes are as follows.
- UPMC for Life (Medicare/Special Needs Plan):
- Part D formularies effective Sept. 1, 2025
- Part B policies effective Sept. 10, 2025
- UPMC Health Plan (Commercial/Exchange) and UPMC for Kids (CHIP): Formularies effective Oct. 1, 2025
- UPMC for You and UPMC CHC: Effective Oct. 1, 2025
For full details on these changes, please refer to pages 18-19 in the September 2025 edition of Provider Partner Update.
Recent Announcements
CME Webinar: First Annual Dr. Jim Withers Lecture
Please join us for the First Annual Dr. Jim Withers Lecture, featuring Dr. Jim Withers, a global leader in compassionate, justice-centered careApr. 2026Education/Webinars
Provider Directory Updates and Required Attestation
As you know, UPMC Health Plan requires all providers to verify their provider directory information at least every 90 days (quarterly).Apr. 2026Important Notices
Voluntary nationwide recall: Alcohol Pads (Cardinal – March)
Cardinal Health is recalling multiple lots of Webcol™ Large Alcohol Prep Pads (70% isopropyl alcohol). Alcohol prep pads are used for external cleansing of the skin.Mar. 2026Pharmacy Updates
